Reuters - Video

Edition: US | UK | IN | CN | JP

video Finance Videos

Shire sells cancer drugs to Servier as Takeda circles

Monday, April 16, 2018 - 01:20

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years.

▲ Hide Transcript

View Transcript

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Shire sells cancer drugs to Servier as Takeda circles

Monday, April 16, 2018 - 01:20